Collectively, these data suggest that SN-401-mediated improvements in systemic glycemia in T2D occur via augmentation of both peripheral insulin sensitivity and β-cell insulin secretion—the inverse phenotype observed in in vivo loss-of-function studies24,28–30. Here, INS is linked to type 2 diabetes mellitus.